Side-by-side financials for ELAB and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ELAB | NVS |
|---|---|---|
| Market cap | - | $282.64 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $590.08K | - |
| Net income (latest FY) | -$7.75M | - |
| Net margin | -1313.0% | - |
| SEC filings | 252 | 947 |
Full pages: Elevai Labs Inc. and Novartis AG, or browse the full rankings.